Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY – Get Free Report)’s stock price was up 2.5% during trading on Thursday . The company traded as high as $8.10 and last traded at $8.09. Approximately 376 shares changed hands during mid-day trading, a decline of 88% from the average daily volume of 3,204 shares. The stock had previously closed at $7.89.
Clinuvel Pharmaceuticals Stock Up 2.5%
The business has a fifty day moving average of $7.79 and a 200 day moving average of $7.31.
Clinuvel Pharmaceuticals Dividend Announcement
The business also recently declared a dividend, which was paid on Monday, September 29th. Shareholders of record on Tuesday, September 9th were issued a dividend of $0.0261 per share. This represents a yield of 35.0%. The ex-dividend date was Monday, September 8th.
About Clinuvel Pharmaceuticals
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).
Featured Stories
- Five stocks we like better than Clinuvel Pharmaceuticals
- How to Capture the Benefits of Dividend Increases
- Salesforce’s Long-Awaited Inflection is Here: Rally On!
- Overbought Stocks Explained: Should You Trade Them?
- Rocket Lab USA Receives Wall Street Validation: Time to Buy?
- How to Calculate Return on Investment (ROI)
- Archer Buys Rival’s Patent Treasure Trove in Strategic Move
Receive News & Ratings for Clinuvel Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinuvel Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
